Literature DB >> 15994040

Oleanolic acid and ursolic acid: research perspectives.

Jie Liu1.   

Abstract

Oleanolic acid and ursolic acid are ubiquitous triterpenoids in plant kingdom, medicinal herbs, and are integral part of the human diet. During the last decade over 700 research articles have been published on their research, reflecting tremendous interest and progress in our understanding of these triterpenoids. This included the isolation and purification of these tritepernoids from various plants and herbs, the chemical modifications to make more effective and water soluble derivatives, the pharmacological research on their beneficial effects, the toxicity studies, and the clinical use of these triterpenoids in various diseases including anticancer chemotherapies. A briefly commentary is attempted here for their research perspectives.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994040     DOI: 10.1016/j.jep.2005.05.024

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  120 in total

1.  Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.

Authors:  Nisha R Parikh; Animesh Mandal; Deepak Bhatia; Kodappully Sivaraman Siveen; Gautam Sethi; Anupam Bishayee
Journal:  Phytochem Rev       Date:  2014-12       Impact factor: 5.374

2.  Enzymatic activity, sensitivity to antifungal drugs and Baccharis dracunculifolia essential oil by Candida strains isolated from the oral cavities of breastfeeding infants and in their mothers' mouths and nipples.

Authors:  Cristiane Aparecida Pereira; Anna Carolina Borges Pereira da Costa; Ana Karina Silva Machado; Miltom Beltrame Júnior; Maria Stella Amorin Costa Zöllner; Juliana Campos Junqueira; Antonio Olavo Cardoso Jorge
Journal:  Mycopathologia       Date:  2010-08-12       Impact factor: 2.574

3.  Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity.

Authors:  Komal Kalani; Dharmendra Kumar Yadav; Feroz Khan; Santosh K Srivastava; Nitasha Suri
Journal:  J Mol Model       Date:  2012-01-21       Impact factor: 1.810

4.  Chios mastic treatment of patients with active Crohn's disease.

Authors:  Andriana C Kaliora; Maria G Stathopoulou; John K Triantafillidis; George V Z Dedoussis; Nikolaos K Andrikopoulos
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

5.  Treatment with triterpenic fraction purified from Baccharis uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice.

Authors:  Eduardo Seiji Yamamoto; Bruno Luiz S Campos; Márcia Dalastra Laurenti; João H G Lago; Simone dos Santos Grecco; Carlos E P Corbett; Luiz Felipe D Passero
Journal:  Parasitol Res       Date:  2013-10-31       Impact factor: 2.289

6.  Steroid-like compounds in Chinese medicines promote blood circulation via inhibition of Na+/K+ -ATPase.

Authors:  Ronald J Y Chen; Tse-yu Chung; Feng-yin Li; Wei-hung Yang; Tzyy-rong Jinn; Jason T C Tzen
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

7.  Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats.

Authors:  Shih-Hsiang Lo; Yingxiao Li; Kai Chun Cheng; Chiang-Shan Niu; Juei-Tang Cheng; Ho-Shan Niu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-30       Impact factor: 3.000

8.  The influence of cosolvent on the complexation of HP-beta-cyclodextrins with oleanolic acid and ursolic acid.

Authors:  Rui Li; Peng Quan; Dong-Fei Liu; Fang-Di Wei; Qing Zhang; Qun-Wei Xu
Journal:  AAPS PharmSciTech       Date:  2009-10-16       Impact factor: 3.246

9.  Benzyl 3-dehydr-oxy-1,2,5-oxadiazolo[3',4':2,3]oleanolate.

Authors:  Jun Hu; Xiaoyun Gong; Ruji Wang; Yong Ju
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-15

10.  Solid dispersion of ursolic acid in Gelucire 50/13: a strategy to enhance drug release and trypanocidal activity.

Authors:  Josimar de Oliveira Eloy; Juliana Saraiva; Sergio de Albuquerque; Juliana Maldonado Marchetti
Journal:  AAPS PharmSciTech       Date:  2012-10-16       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.